自我展示！由MHC I类分子和MHC II类分子完成。
Present Yourself! By MHC Class I and MHC Class II Molecules.
作者信息
Rock Kenneth L, Reits Eric, Neefjes Jacques
机构信息
Department of Pathology, UMass Medical School, Worcester, MA, USA.
Department of Cell Biology and Histology, Amsterdam Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
出版信息
Trends Immunol. 2016 Nov;37(11):724-737. doi: 10.1016/j.it.2016.08.010. Epub 2016 Sep 7.
Abstract
Since the discovery of MHC molecules, it has taken 40 years to arrive at a coherent picture of how MHC class I and MHC class II molecules really work. This is a story of the proteases and MHC-like chaperones that support the MHC class I and II molecules in presenting peptides to the immune system. We now understand that the MHC system shapes both the repertoire of presented peptides and the subsequent T cell response, with important implications ranging from transplant rejection to tumor immunotherapies. Here we present an illustrated review of the ins and outs of MHC class I and MHC class II antigen presentation.
摘要
自MHC分子被发现以来，已经过去了40年，才形成了关于MHC I类和MHC II类分子实际工作方式的连贯图景。这是一个关于蛋白酶和MHC样伴侣蛋白的故事，它们在将肽呈递给免疫系统的过程中支持MHC I类和II类分子。我们现在明白，MHC系统塑造了呈递肽的库以及随后的T细胞反应，其重要影响范围从移植排斥到肿瘤免疫疗法。在这里，我们对MHC I类和MHC II类抗原呈递的来龙去脉进行了图文并茂的综述。
相似文献
1
Present Yourself! By MHC Class I and MHC Class II Molecules.自我展示！由MHC I类分子和MHC II类分子完成。
Trends Immunol. 2016 Nov;37(11):724-737. doi: 10.1016/j.it.2016.08.010. Epub 2016 Sep 7.
2
Comparative study of the role of professional versus semiprofessional or nonprofessional antigen presenting cells in the rejection of vascularized organ allografts.专业抗原呈递细胞与半专业或非专业抗原呈递细胞在血管化器官同种异体移植排斥反应中作用的比较研究。
Transpl Immunol. 1995 Dec;3(4):273-89. doi: 10.1016/0966-3274(95)80013-1.
3
Mouse Schwann cells activate MHC class I and II restricted T-cell responses, but require external peptide processing for MHC class II presentation.小鼠雪旺细胞激活 MHC Ⅰ类和Ⅱ类限制性 T 细胞反应，但需要外源性肽加工来进行 MHC Ⅱ类呈递。
Neurobiol Dis. 2010 Feb;37(2):483-90. doi: 10.1016/j.nbd.2009.11.006. Epub 2009 Nov 13.
4
Chemical biology of antigen presentation by MHC molecules.MHC 分子对抗原呈递的化学生物学。
Curr Opin Immunol. 2014 Feb;26:21-31. doi: 10.1016/j.coi.2013.10.005. Epub 2013 Nov 14.
5
Antigen presentation and T cell stimulation by dendritic cells.树突状细胞的抗原呈递与T细胞刺激
Annu Rev Immunol. 2002;20:621-67. doi: 10.1146/annurev.immunol.20.100301.064828. Epub 2001 Oct 4.
6
Induction of T-cell response to cryptic MHC determinants during allograft rejection.同种异体移植排斥反应期间对隐蔽性主要组织相容性复合体决定簇的T细胞应答诱导
Hum Immunol. 2000 Dec;61(12):1352-62. doi: 10.1016/s0198-8859(00)00209-3.
7
Endosomal compartment: Also a dock for MHC class I peptide loading.内体 compartment：也是 MHC Ⅰ类肽加载的停靠点。
Eur J Immunol. 2014 Mar;44(3):650-3. doi: 10.1002/eji.201444470.
8
Cross-presentation in viral immunity and self-tolerance.病毒免疫与自身耐受中的交叉呈递。
Nat Rev Immunol. 2001 Nov;1(2):126-34. doi: 10.1038/35100512.
9
Turning tumor cells in situ into T-helper cell-stimulating, MHC class II tumor epitope-presenters: immuno-curing and immuno-consolidation.将原位肿瘤细胞转变为刺激辅助性T细胞、呈递II类主要组织相容性复合体肿瘤表位的细胞：免疫治愈与免疫巩固
Cancer Treat Rev. 2004 May;30(3):281-90. doi: 10.1016/j.ctrv.2003.08.002.
10
Carbohydrate-mediated targeting of antigen to dendritic cells leads to enhanced presentation of antigen to T cells.碳水化合物介导的抗原靶向树突状细胞可增强抗原向T细胞的呈递。
Chembiochem. 2008 Jan 25;9(2):294-303. doi: 10.1002/cbic.200700310.
引用本文的文献
1
Immune Responses of Dendritic Cells to Zoonotic DNA and RNA Viruses.树突状细胞对人畜共患DNA和RNA病毒的免疫反应
Vet Sci. 2025 Jul 24;12(8):692. doi: 10.3390/vetsci12080692.
2
A modular vaccine platform for optimized lipid nanoparticle mRNA immunogenicity.一种用于优化脂质纳米颗粒mRNA免疫原性的模块化疫苗平台。
Nat Biomed Eng. 2025 Aug 25. doi: 10.1038/s41551-025-01478-6.
3
In Silico Development of a Multi-epitope Vaccine Targeting TFDP3: A Novel Approach for Cancer Immunotherapy.靶向TFDP3的多表位疫苗的计算机辅助开发：癌症免疫治疗的新方法
Cell Biochem Biophys. 2025 Aug 13. doi: 10.1007/s12013-025-01830-2.
4
Association of HLA-DRA expression with prognosis and tumor microenvironment in clear cell renal cell carcinoma.HLA-DRA表达与透明细胞肾细胞癌预后及肿瘤微环境的关联
Sci Rep. 2025 Aug 10;15(1):29270. doi: 10.1038/s41598-025-13665-1.
5
Identification of distinct epitopes in dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid.二肽基肽酶-4抑制剂相关大疱性类天疱疮中不同表位的鉴定
Sci Adv. 2025 Aug;11(31):eadv9423. doi: 10.1126/sciadv.adv9423. Epub 2025 Aug 1.
6
Sliding Window Interaction Grammar (SWING): a generalized interaction language model for peptide and protein interactions.滑动窗口相互作用语法（SWING）：一种用于肽和蛋白质相互作用的广义相互作用语言模型。
Nat Methods. 2025 Jul 28. doi: 10.1038/s41592-025-02723-1.
7
A structure-guided approach to predict MHC-I restriction of T cell receptors for public antigens.一种基于结构的方法来预测针对公共抗原的T细胞受体的MHC-I限制性。
Structure. 2025 Jul 15. doi: 10.1016/j.str.2025.06.011.
8
Decoding MHC loss: Molecular mechanisms and implications for immune resistance in cancer.解读MHC缺失：癌症免疫抵抗的分子机制及其影响
Clin Transl Med. 2025 Jul;15(7):e70403. doi: 10.1002/ctm2.70403.
9
A Human Tumor-Immune Organoid Model of Glioblastoma.一种胶质母细胞瘤的人类肿瘤-免疫类器官模型。
bioRxiv. 2025 Jun 20:2025.06.16.660009. doi: 10.1101/2025.06.16.660009.
10
A roadmap for T cell receptor-peptide-bound major histocompatibility complex binding prediction by machine learning: glimpse and foresight.通过机器学习预测T细胞受体-肽结合的主要组织相容性复合体的路线图：现状与展望。
Brief Bioinform. 2025 Jul 2;26(4). doi: 10.1093/bib/bbaf327.
本文引用的文献
1
An ER-Associated Pathway Defines Endosomal Architecture for Controlled Cargo Transport.一种内质网相关途径定义了用于受控货物运输的内体结构。
Cell. 2016 Jun 30;166(1):152-66. doi: 10.1016/j.cell.2016.05.078.
2
Specialized proteasome subunits have an essential role in the thymic selection of CD8(+) T cells.专门的蛋白酶体亚基在CD8(+) T细胞的胸腺选择中起关键作用。
Nat Immunol. 2016 Aug;17(8):938-45. doi: 10.1038/ni.3480. Epub 2016 Jun 13.
3
Class-switched anti-insulin antibodies originate from unconventional antigen presentation in multiple lymphoid sites.类别转换抗胰岛素抗体起源于多个淋巴部位的非常规抗原呈递。
J Exp Med. 2016 May 30;213(6):967-78. doi: 10.1084/jem.20151869. Epub 2016 May 2.
4
Variations in MHC Class II Antigen Processing and Presentation in Health and Disease.MHC Ⅱ类抗原加工和呈递在健康和疾病中的差异。
Annu Rev Immunol. 2016 May 20;34:265-97. doi: 10.1146/annurev-immunol-041015-055420. Epub 2016 Feb 22.
5
Interaction of TAPBPR, a tapasin homolog, with MHC-I molecules promotes peptide editing.TAPBPR（一种与塔帕辛同源的蛋白）与主要组织相容性复合体I类（MHC-I）分子的相互作用促进肽段编辑。
Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):E1006-15. doi: 10.1073/pnas.1519894113. Epub 2016 Feb 11.
6
Lung cancer in 2015: Bypassing checkpoints, overcoming resistance, and honing in on new targets.2015年的肺癌研究：绕过检查点、克服耐药性并锁定新靶点。
Nat Rev Clin Oncol. 2016 Feb;13(2):75-6. doi: 10.1038/nrclinonc.2015.223. Epub 2015 Dec 31.
7
TAPBPR alters MHC class I peptide presentation by functioning as a peptide exchange catalyst.TAPBPR通过作为肽交换催化剂发挥作用，改变MHC I类肽的呈递。
Elife. 2015 Oct 6;4:e09617. doi: 10.7554/eLife.09617.
8
Definition of Proteasomal Peptide Splicing Rules for High-Efficiency Spliced Peptide Presentation by MHC Class I Molecules.蛋白酶体肽剪接规则的定义，用于通过I类主要组织相容性复合体分子高效呈递剪接肽。
J Immunol. 2015 Nov 1;195(9):4085-95. doi: 10.4049/jimmunol.1402455. Epub 2015 Sep 23.
9
The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell-based immunotherapy.多发性骨髓瘤的抗原格局：质谱分析（重新）定义基于T细胞的免疫疗法的靶点。
Blood. 2015 Sep 3;126(10):1203-13. doi: 10.1182/blood-2015-04-640532. Epub 2015 Jul 2.
10
Cross-Presentation in Mouse and Human Dendritic Cells.小鼠和人树突状细胞中的交叉呈递。
Adv Immunol. 2015;127:1-31. doi: 10.1016/bs.ai.2015.03.002. Epub 2015 Apr 8.
Zotero 插件